SMARCA2 and triple-negative breast carcinoma: In addition, we have previously shown that knockdown of either BRG1 or BRM in triple negative breast cancer cell lines results in increased expression of the remaining ATPase [22] and that both BRG1 and BRM contribute to triple negative cell proliferation [30].